Paasa Logo
Qiagen N.V. logo
QIAXETRAMarket openCloses 5:30pm CET

Qiagen N.V.

€39.24Last updated
-€0.07 (0.18%)Past day
Timezone

Qiagen N.V. (XETRA: QIA) is trading at €39.24, about ₹4,288 at today's EUR/INR rate, as of 29 Sep 2026, 10:25 AM ET, down 0.18% today. Indian residents can buy Qiagen from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:€39.52
Previous close:€39.31
Volume:206.08K

Today's low

€38.79

Today's high

€39.64

52 week low

€27.56

52 week high

€47.60

QIA opened at €39.52, closed previously at €39.31, and has traded between €27.56 and €47.60 over the past 52 weeks.

About

QIAGEN N.V. delivers comprehensive "sample to insight" solutions globally, enabling the transformation of biological materials into valuable molecular insights. Their extensive product portfolio addresses various stages of molecular analysis, starting with primary sample technologies. This includes a range of consumables such as kits for nucleic acid stabilization and purification from initial biological samples, as well as manual and automated processing systems for applications like genotyping, gene expression, and viral or bacterial analysis, often utilizing advanced silica membrane and magnetic bead methodologies. They also supply components and kits for purifying nucleic acids from secondary sample types, alongside dedicated instruments and accessories for efficient nucleic acid purification. The company's broad suite of assays covers critical diagnostic and research areas. These include interferon-gamma release tests for tuberculosis, assays for post-transplant monitoring and viral load assessment, and solutions for prenatal testing, detection of sexually transmitted diseases, and human papillomavirus (HPV). Furthermore, QIAGEN provides assays for analyzing complex genomic variants, such as mutations, insertions, deletions, and fusions. For streamlined diagnostics, their "sample to insight" instruments facilitate one-step molecular analysis for challenging syndromes and integrate PCR testing capabilities. QIAGEN also develops and supplies an array of PCR consumables, including quantitative PCR, reverse transcription, and combination kits, essential for gene expression analysis, genotyping, and gene regulation studies. Their offerings extend to human identification and forensics, with STR assays and kits for food contamination detection. The company also features PCR instruments, including cutting-edge digital PCR solutions, and custom-developed OEM consumables. Further bolstering their capabilities, QIAGEN provides predefined and customizable Next-Generation Sequencing (NGS) gene panels, alongside library preparation kits, components, and whole genome amplification solutions. Complementing their vast selection of consumables and instruments, the company offers robust bioinformatics solutions and specialized custom laboratory and genomic services. Serving a diverse customer base, QIAGEN caters to molecular diagnostics laboratories, academic research institutions, pharmaceutical companies, and applied testing sectors. Strategic alliances are maintained with Sysmex Corporation, OncXerna Therapeutics, and Mirati. Founded in 1986, QIAGEN N.V. maintains its corporate headquarters in Venlo, the Netherlands.

Country
NL
CEO
Jon Pratt
Exchange listed on
XETRA
Industry
Medical - Diagnostics & Research
Base currency
EUR
Full Time Employees
5,654
Sector
Healthcare
IPO date
22/07/1998

Key statistics

Avg. volume

640.96K

Market cap

€8.09B

P/E Ratio

22.83

Price-to-sales ratio

4.37

Enterprise value

$10.06B

Free cash flow yield

4.88%

Debt-to-equity ratio

0.49

Return on equity

11.60%

ROIC

8.86%

Beta

0.62

Dividend yield

5.93%

Last dividend

€2.41

Financial overview

Revenue

$2.09B

Earnings per share

$2.04

Free cash flow

$453.31M

Net profit margin

19.49%

Gross margin

61.82%

EBITDA

$717.32M

Revenue growth

5.66%

Similar securities

This is not an investment recommendation

How to buy Qiagen from India

Indian residents can buy Qiagen shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to EUR.

  3. Search for Qiagen and place an order

    Find Qiagen by name or by its ticker, QIA, and choose an order type. Qiagen trades 12:30 pm – 9:00 pm IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Qiagen position in EUR and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.

Read the full guide: how to invest in Qiagen from India

Trading and taxes when buying Qiagen from India

Trading and limits

Trading hours
9:00 am – 5:30 pm CET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
Slab rateDividends are taxed at your slab rate in India. Qiagen’s current yield is 5.93%.Dividend tax explained

Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

FAQs

Can Indian residents buy Qiagen stock?

Yes. Qiagen (QIA) has been listed on XETRA since 1998, in the Medical - Diagnostics & Research industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to EUR. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

How much does one Qiagen share cost in rupees?

One Qiagen share is €39.24 — about ₹4,288 at an EUR/INR rate of 109.29 on 28 Sep 2026. Both the Qiagen price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Qiagen from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

How are gains on Qiagen shares taxed in India?

Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the EUR/INR rate on the purchase and the sale date, so the rupee move counts alongside the Qiagen price. Paasa issues a capital-gains statement for your return.

Does Qiagen pay a dividend, and how is it taxed in India?

Yes. Qiagen pays a dividend and the current yield is 5.93%; the last declared dividend was €2.41 per share, about ₹263.42. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.

When can I trade Qiagen from India?

XETRA trades 12:30 pm – 9:00 pm IST in Indian time. The window shifts to 1:30 pm – 10:00 pm IST when Germany is on standard time. Orders can only execute during that window.

Is Qiagen a Germany company, and does that change how it is taxed?

Qiagen trades on XETRA in EUR, but the company is domiciled in Netherlands. Qiagen trades as an ordinary share listed directly in Germany, not a depositary receipt. Your India-side capital-gains treatment is the same either way.

Do I have to declare Qiagen shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Qiagen holding, its cost and its closing value.

How do I sell Qiagen and bring the money back to India?

You sell during market hours (12:30 pm – 9:00 pm IST) and the proceeds settle in EUR in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.

Does the rupee rate affect what I make on Qiagen?

Yes. Qiagen is priced in EUR, so your rupee outcome combines the EUR move with the EUR/INR move between the day you remit and the day you convert back. Both directions are reflected in the capital-gains statement Paasa issues.